US FDA halts Sun Pharma's trials on dermatological drug

The FDA has also said that patients with alopecia areata - an autoimmune condition that results in patchy hair loss - on the 12 mg dose of the drug deuruxolitinib should discontinue its use, Sun Pharma said.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/IWJFRmb
via IFTTT